MEDANTA — Global Health Cashflow Statement
0.000.00%
- IN₹322.63bn
- IN₹319.34bn
- IN₹32.75bn
Annual cashflow statement for Global Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 639 | 325 | 2,806 | 4,493 | 6,271 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 502 | 659 | 658 | 486 | 429 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -541 | 202 | -1,648 | -33.3 | -2,306 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,751 | 2,418 | 3,113 | 6,445 | 6,121 |
Capital Expenditures | -1,883 | -1,457 | -2,745 | -2,360 | -2,786 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1,012 | -934 | -1,464 | -1,064 | -1,622 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -871 | -2,392 | -4,209 | -3,423 | -4,408 |
Financing Cash Flow Items | -790 | -624 | -767 | -923 | -567 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -8.83 | -807 | 1,596 | 3,456 | -5,139 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 871 | -781 | 500 | 6,478 | -3,426 |